Evidence map›Paper›PMID 39527217›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Mouse Models Enable the Functional Investigation of Tertiary Lymphoid Structures in Cancer.

Advait Jeevanandam, Zixi Yin, Kelli A Connolly, Nikhil S Joshi

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Advait JeevanandamDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Zixi YinDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Kelli A ConnollyDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Nikhil S JoshiDepartment of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. Nikhil.joshi@yale.edu.

Funding

Developing translationally-relevant genetically engineered mouse models of lung adenocarcinoma for investigations in cancer immunologyR01CA237037 · NCI · YALE UNIVERSITY · PI JOSHI, NIKHIL · 2020 to 2024
$2.7M
Investigating the development and maintenance of tumor-associated tertiary lymphoid structures in an autochthonous mouse model of lung adenocarcinomaK22CA200912 · NCI · YALE UNIVERSITY · PI JOSHI, NIKHIL · 2016 to 2018
$587k
NCI NIH HHS K22 CA200912NCI NIH HHS R01 CA237037
6 · The paper itself

Abstract

Tertiary lymphoid structures (TLSs) are organized lymphoid aggregates that form within nonlymphoid tissue, including tumors, in response to persistent inflammatory stimulation. In cancer patients, TLSs are generally associated with positive clinical outcomes. However, the cellular composition and spatial distribution of TLSs can vary depending on the underlying disease state, complicating interpretations of their prognostic significance. Murine models are indispensable for providing a deeper insight into the mechanisms involved in TLS formation and function. Studies using these models can complement current clinical efforts to characterize TLSs via genetic sequencing and histopathology of human samples. Several features of TLSs resemble that of secondary lymphoid organs (SLOs). Consequently, vascular system components and structural support elements are important for TLS formation and maintenance. Furthermore, TLSs in different tissue environments can exhibit distinct characteristics, necessitating careful consideration when selecting mouse models for study. Herein, we discuss critical aspects to consider when modeling TLSs and describe recent findings of TLS studies in the mouse lung and intestinal gut environments as examples to highlight the importance of considering tissue-specific regulatory mechanisms for TLSs. In this chapter, we also summarize the mechanistic insights derived from murine models on the formation and function of TLSs, which may translate to the future therapeutic modulation of TLS in disease.

Indexed as

Disease Models, AnimalNeoplasmsTertiary Lymphoid StructuresAnimalsHumansLungMiceTumor MicroenvironmentCancerFormationMurine modelRegulationTertiary lymphoid structure

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.